Page 10 - Cassava Sciences News Today

Wall Street analysts foresee up to 316% upside in three fast-paced companies in the new year.

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

The company has chosen an offbeat way to keep its investors sweet.

Cassava Sciences, Inc. (NASDAQ:SAVA – Free Report) shares are going to split on the morning of Thursday, December 21st. The 14-10 split was announced on Thursday, December 21st. The newly created shares will be distributed to shareholders after the closing bell on Thursday, December 21st. Cassava Sciences Price Performance NASDAQ SAVA traded down $0.31 during […]

Cassava Sciences sees its Relative Strength Rating reach the 80-plus level. The post Cassava Sciences Stock Shows Rising Relative Strength Following 3 Up Days…

Shares of pharmaceutical specialist Cassava Sciences (NASDAQ:SAVA) soared earlier Tuesday before giving up most of the gains. Nevertheless, investor…

Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 1,571,904 shares traded hands during mid-day trading, an increase of 51% from the previous session’s volume of 1,042,410 shares.The stock last traded at $27.78 and had previously closed at $24.39. Cassava Sciences Price Performance The business has a […]

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday on continued upward momentum. The stock has gained more than 20% over than last five days. What To Know:

Investors cheered the arrival of a trio of new board members.

Dr. Nicaise, Mr. Gravier and Mr. Anderson have years of experience in drug development, healthcare M&A and working with the U.S. GovernmentAUSTIN, Texas, Dec. 07, 2023 -- Cassava Sciences, Inc. , a...